Clinical activity of enzalutamide against metastatic castration-resistant prostate cancer (mCRPC) in patients who have progressed on abiraterone acetate: The Princess Margaret experience.
暂无分享,去创建一个
I. Tannock | J. Knox | F. Vera-Badillo | S. Sridhar | A. Joshua | A. Templeton | R. Leibowitz-Amit | J. Seah